Pecs II block for Tendonitis

Phase-Based Progress Estimates
3
Effectiveness
3
Safety
NYU Langone Health, New York, NYTendonitisPecs II block - Drug
Eligibility
18 - 75
All Sexes
What conditions do you have?
Select

Study Summary

This trial looks at two ways to control pain after surgery, and whether one is better than the other at reducing pain and the need for pain medication.

Eligible Conditions
  • Tendonitis

Treatment Effectiveness

Effectiveness Progress

3 of 3
This is further along than 93% of similar trials

Similar Trials

1
Combined serratus anterior plane block and transversus thoracis plane block
2
Bupivacaine
1
Rectus Sheath Block with 0.25% bupivicaine with 1:200 000 epinephrine

Study Objectives

1 Primary · 5 Secondary · Reporting Duration: 24-48 hours

24 hours
Incidence of patient reaction to surgical subpectoral incision
Opioid utilization for the first 24 hours after surgery, including during surgery, calculated as oxycodone equivalent
Patient reported Visual Analog Scale (VAS) scores in PACU
Presence or absence of sensation to cold and pinprick in PACU
24-48 hours
Patient reported Visual Analog Scale (VAS) score at postoperative day 1 (POD 1)
72 hours
Patient reported Visual Analog Scale (VAS) score at postoperative day 3 (POD 3)

Trial Safety

Safety Progress

3 of 3
This is further along than 85% of similar trials

Similar Trials

1
Combined serratus anterior plane block and transversus thoracis plane block
3
Bupivacaine
2
Rectus Sheath Block with 0.25% bupivicaine with 1:200 000 epinephrine

Trial Design

2 Treatment Groups

Surgical infiltration
1 of 2
Pecs II block
1 of 2

Active Control

Experimental Treatment

160 Total Participants · 2 Treatment Groups

Primary Treatment: Pecs II block · No Placebo Group · Phase 4

Pecs II block
Drug
Experimental Group · 1 Intervention: Pecs II block · Intervention Types: Drug
Surgical infiltration
Drug
ActiveComparator Group · 1 Intervention: Surgical infiltration · Intervention Types: Drug
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
Pecs II block
2014
N/A
~80

Trial Logistics

Trial Timeline

Screening: ~3 weeks
Treatment: Varies
Reporting: 24-48 hours

Who is running the clinical trial?

NYU Langone HealthLead Sponsor
1,276 Previous Clinical Trials
758,051 Total Patients Enrolled
Arthur Hertling, MDPrincipal InvestigatorNYU Langone Health
3 Previous Clinical Trials
256 Total Patients Enrolled

Eligibility Criteria

Age 18 - 75 · All Participants · 2 Total Inclusion Criteria

Mark “Yes” if the following statements are true for you:
You are having shoulder surgery that includes a procedure called open subpectoral biceps tenodesis.
References

Frequently Asked Questions

What is the participant enrollment size of this investigation?

"Affirmative. The online resource clinicaltrials.gov indicates that this research project, first posted on July 14th 2021, is actively recruiting participants. 160 patients need to be identified from a single medical site." - Anonymous Online Contributor

Unverified Answer

What qualifications are needed to participate in this research project?

"This clinical research is seeking 160 individuals with tendonitis, aged 18-75. To quality for the study, prospective participants must be within this age range and have already undergone shoulder arthroscopy with open subpectoral biceps tenodesis." - Anonymous Online Contributor

Unverified Answer

Does this trial cater to participants younger than thirty years of age?

"This clinical trial has set a lower age limitation of 18 and an upper limit of 75 for patient enrollment, in compliance with the stated criteria." - Anonymous Online Contributor

Unverified Answer

Are participants currently being recruited for this research project?

"Affirmative. Clinicaltrials.gov's records indicate that this trial is currently recruiting participants, having been first posted on July 14th 2021 and recently updated on June 14th 2022. The study aims to include 160 patients from a single site of research." - Anonymous Online Contributor

Unverified Answer

What potential harms could result from a Pecs II block procedure?

"Our team has assigned Pecs II block a score of 3, as it is in its fourth phase and thus already approved for use." - Anonymous Online Contributor

Unverified Answer
Please Note: These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top